Top Markets
#1 ADO Protocol ADO Protocol +195.51%
#2 Islamic Coin Islamic Coin +155.46%
#3 GoPlus Security GoPlus Security +59.58%
#4 Verus Coin Verus Coin +33.00%
#5 Starpower Starpower +27.12%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +15.11%
#8 Status Status +14.31%
#9 The Black Bull The Black Bull +12.35%
#10 o1.exchange o1.exchange +11.85%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Marvel Biosciences Corp. Marvel Biosciences Corp.

Marvel Biosciences Corp.

MRVL
Rank in Stocks #33329
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical... Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company’s lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer’s disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Share Price
$0.12476927
Last synced: 2026-08-14
Market Cap
$7.86M
Change (1 day)
6.25%
Change (1 year)
-19.80%
Country
CA
Trade Marvel Biosciences Corp. (MRVL)

Category

Healthcare
Stock price history for Marvel Biosciences Corp. (MRVL)
Highest end of day price: $0.12 on 2026-08-01

Lowest end of day price: $0.22 on 2021-07-01
Stock price history of Marvel Biosciences Corp. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 14.35%
2025 0.18%
2024 70.49%
2023 -36.24%
2022 -50.31%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.12 7.12%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.38 13.33%
BE